From Casetext: Smarter Legal Research

Cephalon, Inc. v. Watson Pharms. Inc.

United States Court of Appeal for the Federal Circuit
Sep 14, 2011
2011-1325 (Fed. Cir. Sep. 14, 2011)

Opinion

2011-1325

09-14-2011

CEPHALON, INC. and CIMA LABS, INC., Plaintiffs-Appellants, v. WATSON PHARMACEUTICALS, INC., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendants-Appellees.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the District of Delaware in case no. 08-CV-0330, Judge Sue L. Robinson.

ON MOTION


ORDER

Cephalon, Inc. and CIMA Labs, Inc., move for a 30-day extension of time, until October 17, 2011, to file their opening brief due to settlement negotiations.

Upon consideration thereof,

IT IS ORDERED THAT:

FOR THE COURT

cc: William F. Lee, Esq.

James K. Stronski, Esq.

Jan Horbaly

Clerk


Summaries of

Cephalon, Inc. v. Watson Pharms. Inc.

United States Court of Appeal for the Federal Circuit
Sep 14, 2011
2011-1325 (Fed. Cir. Sep. 14, 2011)
Case details for

Cephalon, Inc. v. Watson Pharms. Inc.

Case Details

Full title:CEPHALON, INC. and CIMA LABS, INC., Plaintiffs-Appellants, v. WATSON…

Court:United States Court of Appeal for the Federal Circuit

Date published: Sep 14, 2011

Citations

2011-1325 (Fed. Cir. Sep. 14, 2011)